Subscribe to Newsletter

Refine results:

Refine results

Product Profiles

Results 21–30 of 233

Bringing solutions to the ever-increasing needs of the consumer healthcare market

| Contributed by Qualicaps

Qualicaps® keeps on broadening its product portfolio with the launch of a new range of TiO2-free capsules.

Integrated and Flexible Clinical Supply Solutions

| Contributed by Catalent

Catalent has more than 25 years’ experience as a global leader in clinical supply services

New heating and cooling concept with the innovative ISF1-Z Peltier incubator shaker

| Contributed by Kuhner shaker

The ISF1-Z incubator shaker is suitable for applications in laboratories, research centers and production facilities.

Experience speed, sensitivity, and accuracy in your antibody screening

| Contributed by Bio-Rad Laboratories

Learn how the ZE5 Cell Analyzer can actualize high-throughput with automation-ready robotic features

BPS Crowthorne - Validation and Servicing of Cleanrooms and Laboratories

| Contributed by BPS Crowthorne

BPS Crowthorne offers specialist servicing, independent inspection and compliance validation of critical clean air systems

Quali-G™ Liquid capsules, the best choice of hard capsule for very low viscosity liquid filling operations

| Contributed by Qualicaps

Qualicaps® now offers Quali-G™ Liquid, the definitive solution for encapsulation of very low viscosity liquids at room temperature in hard capsules.

Johnson Matthey provides an extensive range of APIs covering a wide range of therapeutics classes

| Contributed by Johnson Matthey

JM's API portfolio includes voxelotor, a ground-breaking drug used to treat sickle cell disease.

Catalent Cell & Gene Therapy

| Contributed by Catalent

Catalent Cell & Gene Therapy is a full-service partner for a number of cell and gene technology platforms

Quali-V® Extra Dry capsules, for use when a minimum moisture content is required

| Contributed by Qualicaps

The stability, activity, & expiry date of several APIs under certain environmental conditions depend on the moisture content to which they are exposed

Crystallisation development provides the first-choice opportunity to innovative particle design

| Contributed by Johnson Matthey

Crystallisation is a key unit operation in manufacturing APIs, however time and costs pressures have previously limited this.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register